Hormonstatus Frau prämenopausal (Premenopausal Female Hormone Panel)

Comprehensive general health screening analyzing 22 biomarkers for cardiovascular, metabolic, liver, kidney, and thyroid function. Venous blood sample with fasting required (8-12 hours). Results typically within 2-3 business days via patient portal (patientenauskunft.mdi-limbach-berlin.de) using 8-digit order number. Price based on GOÄ 1.0 fee scale for statutory health insurance patients; privately insured patients billed at 1.15x multiplier. Ideal for annual health monitoring and disease prevention. Biomarkers tested: Blood Chemistry - alkaline phosphatase (bone and liver enzyme), bilirubin (liver function, bile flow), calcium (bone health, nerve function), total protein (nutrition status, liver/kidney function), urea (kidney function), potassium (electrolyte balance, heart rhythm), sodium (fluid balance, blood pressure); Blood Count - large blood count (CBC with differential) detecting anemia, infection, immune disorders including RBC, WBC, hemoglobin, hematocrit, platelets, neutrophils, lymphocytes, monocytes, eosinophils, basophils; Cardiovascular - total cholesterol, HDL cholesterol ("good"), LDL cholesterol ("bad"), triglycerides (fat metabolism); Inflammation - CRP (C-reactive protein, acute inflammation marker); Liver - gamma-GT (alcohol consumption, bile flow), GOT/ASAT (liver cell damage), GPT/ALAT (liver inflammation); Metabolism - fasting glucose (diabetes screening), HbA1c implicitly assessed, uric acid (gout risk); Kidney - creatinine (filtration), urea (protein metabolism); Thyroid - TSH (thyroid stimulating hormone for hyper/hypothyroidism). Covers all major organ systems for comprehensive preventive health assessment. Appointment booking via Doctolib, phlebotomy €4.20 additional.

Specialized nutritional status screening for vegetarians and vegans analyzing 11 biomarkers commonly deficient in plant-based diets. Venous blood sample with fasting recommended. Results via patient portal within 3-5 days. Essential for anyone following plant-based diet to detect and prevent nutritional deficiencies affecting energy, immunity, cardiovascular and cognitive health. Biomarkers tested: Blood Count - small blood count (CBC) including RBC, WBC, hemoglobin, hematocrit, platelets detecting anemia from B12/iron deficiency; Minerals - calcium (bone health, nerve transmission, muscle function), iron (oxygen transport, energy production), ferritin (iron stores, most sensitive indicator of iron deficiency), selenium (antioxidant, immune function, thyroid health), zinc (immune function, wound healing, taste/smell, DNA synthesis); Vitamins - holotranscobalamin (active vitamin B12, earliest marker of B12 deficiency before anemia develops, critical for vegans), vitamin D 25-OH (bone health, immune function, mood - often low in northern climates regardless of diet); Cardiovascular/Energy - coenzyme Q10 (cellular energy production, antioxidant, heart health), omega-3 fatty acids (EPA+DHA levels, brain health, inflammation reduction - typically low in vegans without algae supplementation); Protein Status - total protein (adequate amino acid intake from plant sources). Comprehensive assessment addresses highest-risk nutrients in plant-based diets. Recommended annually or when experiencing fatigue, weakness, or starting plant-based diet. GOÄ 1.0 pricing; privately insured 1.15x.

Cardiovascular risk assessment panel for athletes and active adults over 30 analyzing 5 lipid biomarkers critical for heart health during intensive training. Venous blood sample with 12-hour fasting required for accurate lipid measurement. Results within 2 days. Exercise increases cardiovascular demands - this panel identifies athletes at risk for atherosclerosis, heart attack, or stroke despite high fitness levels. Important because athletes can have "hidden" cardiovascular risks masked by overall fitness. Biomarkers tested: Lipid Panel - total cholesterol (overall cardiovascular risk), HDL cholesterol ("good" cholesterol, protective against heart disease, should be elevated in athletes), LDL cholesterol ("bad" cholesterol causing arterial plaque, target <100 mg/dL for athletes), lipoprotein(a) [Lp(a)] (genetic cardiovascular risk factor unaffected by diet/exercise, strong predictor of heart attack and stroke); Long-term Glucose Control - HbA1c (glycated hemoglobin reflecting 2-3 month average blood sugar, diabetes screening, metabolic health assessment - athletes should have optimal glucose control). Critical for: masters athletes resuming training, endurance athletes with family history of heart disease, strength athletes using supplements affecting lipids, anyone over 30 starting intensive exercise program. Lp(a) testing is particularly valuable as this genetic risk factor is often overlooked. Should be combined with Sport-Check Plus for comprehensive athletic health assessment. GOÄ 1.0 pricing.

Comprehensive female reproductive hormone panel for women of childbearing age (typically 20-45 years) analyzing 4 key hormones regulating menstrual cycle, fertility, mood, and metabolic health. Venous blood sample with timing critical - ideally collected on Day 3-5 of menstrual cycle for FSH/LH/estradiol, Day 21 for progesterone (or 7 days before expected period). Results within 2-3 days. Essential for evaluating: irregular periods, fertility issues, PCOS, unexplained weight gain, mood disorders, low libido, PMS symptoms. Biomarkers tested: FSH (follicle-stimulating hormone) - controls egg maturation and ovarian function, elevated levels suggest diminished ovarian reserve or approaching menopause, low levels suggest pituitary dysfunction; LH (luteinizing hormone) - triggers ovulation mid-cycle, LH:FSH ratio >2:1 suggests PCOS, absent LH surge indicates anovulation; Estradiol (E2) - primary estrogen hormone, regulates menstrual cycle, bone density, cardiovascular health, brain function, libido, low levels cause irregular periods, hot flashes, vaginal dryness, high levels suggest ovarian cysts or estrogen dominance; Progesterone - produced after ovulation in luteal phase, maintains early pregnancy, balances estrogen, levels <10 ng/mL suggest anovulation or luteal phase defect, adequate levels (>10 ng/mL) confirm ovulation occurred. Panel interpretation requires understanding cycle timing and patient age. Abnormal patterns: PCOS (high LH:FSH ratio, high androgens), hypothalamic amenorrhea (low all hormones), premature ovarian insufficiency (high FSH, low estradiol). GOÄ 1.0 pricing; privately insured 1.15x. Recommend consultation with gynecologist or endocrinologist for interpretation.